Pooled safety analyses from the teriflunomide clinical development program

被引:0
|
作者
Leist, T. P. [1 ]
Freedman, M. S. [2 ,3 ]
Kappos, L. [4 ]
Olsson, T. P. [5 ]
Miller, A. E. [6 ]
Wolinsky, J. S. [7 ]
O'Connor, P. W. [8 ]
Benamor, M. [9 ]
Truffinet, P. [9 ]
Dukovic, D. [10 ]
Comi, G. [11 ]
机构
[1] Thomas Jefferson Univ Hosp, Comprehens Multiple Sclerosis Ctr, Philadelphia, PA 19107 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Basel Hosp, CH-4031 Basel, Switzerland
[5] Karolinska Inst, Stockholm, Sweden
[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[7] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[8] Univ Toronto, Toronto, ON, Canada
[9] Genzyme, Chilly Mazarin, France
[10] Sanofi Rech, Bridgewater, NJ USA
[11] Uni Vita Salute San Raffaele, Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P097
引用
收藏
页码:110 / 111
页数:2
相关论文
共 50 条
  • [31] Teriflunomide: pooled hepatic safety outcomes from placebo-controlled studies and long-term extensions
    Marziniak, M.
    Freedman, M. S.
    Benamor, M.
    Truffinet, P.
    Thangavelu, K.
    Leist, T. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 201 - 201
  • [32] Long-Term Safety from the Raltegravir Clinical Development Program
    Teppler, Hedy
    Brown, Deborah D.
    Leavitt, Randi Y.
    Sklar, Peter
    Wan, Hong
    Xu, Xia
    Lievano, Fabio
    Lehman, Heidi P.
    Mast, T. Christopher
    Nguyen, Bach-Yen T.
    CURRENT HIV RESEARCH, 2011, 9 (01) : 40 - 53
  • [33] Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses
    Angel R. Chinea Martinez
    Jorge Correale
    Patricia K. Coyle
    Xiangyi Meng
    Nadia Tenenbaum
    Advances in Therapy, 2014, 31 : 1072 - 1081
  • [34] Safety of Guselkumab in Patients With Moderate to Severe Psoriasis: Pooled Analyses Across Clinical Studies
    Lebwohl, M.
    Rowland, K.
    Miller, M.
    Yang, Y.
    Yu, J.
    You, Y.
    Chan, D.
    Langley, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S200 - S200
  • [35] Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses
    Martinez, Angel R. Chinea
    Correale, Jorge
    Coyle, Patricia K.
    Meng, Xiangyi
    Tenenbaum, Nadia
    ADVANCES IN THERAPY, 2014, 31 (10) : 1072 - 1081
  • [36] Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials
    Halken, Susanne
    Roberts, Graham
    Valovirta, Erkka
    Nolte, Hendrik
    Hulstrom, Veronica
    Blaiss, Michael S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (04): : 1387 - +
  • [37] Safety and tolerability of teriflunomide in MS patients in clinical practice
    Oreja-Guevara, C.
    Gonzalez-Suarez, I.
    Lopez de Velasco, V.
    Matias-Guiu, J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S247 - S247
  • [38] Safety and tolerability of teriflunomide in MS patients in clinical practice
    Oreja-Guevara, C.
    Gonzalez-Suarez, I.
    Lopez de Velasco, V.
    Matias-Guiu, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 369 - 369
  • [39] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RA
    Walker, David
    Winthrop, Kevin
    Genovese, Mark C.
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitiz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lie
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    RHEUMATOLOGY, 2020, 59
  • [40] Frequency of Infections during Treatment with Teriflunomide: Pooled Data from Three Placebo-Controlled Teriflunomide Studies
    Singer, Barry
    Comi, Giancarlo
    Miller, Aaron
    Olsson, Tomas
    Wolinsky, Jerry
    Kappos, Ludwig
    Confavreux, Christian
    Freedman, Mark
    Benzerdjeb, Hadj
    Li, Huiling
    Truffinet, Philippe
    O'Connor, Paul
    NEUROLOGY, 2013, 80